These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

428 related items for PubMed ID: 17365218

  • 1. Issues with statistical risks for testing methods in noninferiority trial without a placebo ARM.
    Hung HM, Wang SJ, O'Neill R.
    J Biopharm Stat; 2007; 17(2):201-13. PubMed ID: 17365218
    [Abstract] [Full Text] [Related]

  • 2. Mixed noninferiority margin and statistical tests in active controlled trials.
    Tsou HH, Hsiao CF, Chow SC, Yue L, Xu Y, Lee S.
    J Biopharm Stat; 2007; 17(2):339-57. PubMed ID: 17365228
    [Abstract] [Full Text] [Related]

  • 3. Choice of delta noninferiority margin and dependency of the noninferiority trials.
    Tsong Y, Zhang J, Levenson M.
    J Biopharm Stat; 2007; 17(2):279-88. PubMed ID: 17365224
    [Abstract] [Full Text] [Related]

  • 4. Simultaneous test for superiority and noninferiority hypotheses in active-controlled clinical trials.
    Tsong Y, Zhang J.
    J Biopharm Stat; 2007; 17(2):247-57. PubMed ID: 17365221
    [Abstract] [Full Text] [Related]

  • 5. Challenges and regulatory experiences with non-inferiority trial design without placebo arm.
    Hung HM, Wang SJ, O'Neill R.
    Biom J; 2009 Apr; 51(2):324-34. PubMed ID: 19358213
    [Abstract] [Full Text] [Related]

  • 6. Noninferiority testing beyond simple two-sample comparison.
    Tsong Y, Chen WJ.
    J Biopharm Stat; 2007 Apr; 17(2):289-308. PubMed ID: 17365225
    [Abstract] [Full Text] [Related]

  • 7. Statistical issues on objective, design, and analysis of noninferiority active-controlled clinical trial.
    Tsong Y, Wang SJ, Hung HM, Cui L.
    J Biopharm Stat; 2003 Feb; 13(1):29-41. PubMed ID: 12635901
    [Abstract] [Full Text] [Related]

  • 8. The adjustment of the type I error rate in noninferiority trials with λ-margin approach: each of two different new drugs is approved with two independent trials with the same active control.
    Kang SH, Ryu Y.
    J Biopharm Stat; 2011 May; 21(3):498-510. PubMed ID: 21442522
    [Abstract] [Full Text] [Related]

  • 9. Hypotheses and type I error in active-control noninferiority trials.
    Chen G, Wang YC, Chi GY.
    J Biopharm Stat; 2004 May; 14(2):301-13. PubMed ID: 15206528
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Randomization as a basis for inference in noninferiority trials.
    Wiens BL.
    Pharm Stat; 2006 May; 5(4):265-71. PubMed ID: 17128425
    [Abstract] [Full Text] [Related]

  • 12. Placebo or active control trials of antipsychotic drugs?
    Fleischhacker WW, Czobor P, Hummer M, Kemmler G, Kohnen R, Volavka J.
    Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Avoiding ambiguity with the Type I error rate in noninferiority trials.
    Kang SH.
    J Biopharm Stat; 2016 May; 26(3):452-65. PubMed ID: 26252624
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Some fundamental issues with non-inferiority testing in active controlled trials.
    James Hung HM, Wang SJ, Tsong Y, Lawrence J, O'Neil RT.
    Stat Med; 2003 Jan 30; 22(2):213-25. PubMed ID: 12520558
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tests of noninferiority via rate difference for three-arm clinical trials with placebo.
    Tang ML, Tang NS.
    J Biopharm Stat; 2004 May 30; 14(2):337-47. PubMed ID: 15206531
    [Abstract] [Full Text] [Related]

  • 20. TACT method for non-inferiority testing in active controlled trials.
    Wang SJ, Hung HM.
    Stat Med; 2003 Jan 30; 22(2):227-38. PubMed ID: 12520559
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.